Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2002 Aug;57(8):719–723. doi: 10.1136/thorax.57.8.719

A prospective study of change in bone mineral density over one year in adults with cystic fibrosis

C Haworth 1, P Selby 1, A Horrocks 1, E Mawer 1, J Adams 1, A Webb 1
PMCID: PMC1746411  PMID: 12149534

Abstract

Background: Low bone mineral density (BMD) is prevalent in adults with cystic fibrosis. To identify appropriate therapeutic strategies and the optimal time for intervention, it is necessary to document the natural history of cystic fibrosis related low BMD.

Methods: 114 adults with cystic fibrosis underwent bone densitometry a median (25–75% interquartile range) of 12 (12–13) months after initial assessment of bone density. BMD was measured in the lumbar spine, femoral neck, total hip, and distal forearm on recruitment to the trial and at follow up.

Results: In patients ≤24 years of age (n=55, mean (SD) age 19.5 (2.6) years) in whom an annual increase in BMD would normally be expected, BMD increased by a mean (95% CI) 2.9% (1.6 to 4.2) per year in the distal forearm (p<0.001), but decreased by 2.5% (95% CI –3.8 to –1.2) per year in the femoral neck (p<0.001) and by 2.2% (95% CI –3.3 to –1.0) per year in the total hip (p<0.001). In patients ≥25 years of age (n=59, mean (SD) age 30.3 (5.4) years) in whom no annual change in BMD would normally be expected, BMD decreased by 1.9% (95% CI –2.9 to –0.8) per year in the femoral neck (p<0.001), by 1.5% (95% CI –2.4 to –0.6) per year in the total hip (p=0.001), and by 0.8% (95% CI –1.5 to –0.1) per year in the distal forearm (p=0.026). There was no significant annual change in lumbar spine BMD in either patient cohort.

Conclusions: Reduced rates of bone accretion and accelerated rates of bone loss explain the high prevalence of low BMD in adults with cystic fibrosis.

Full Text

The Full Text of this article is available as a PDF (135.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aris R. M., Lester G. E., Dingman S., Ontjes D. A. Altered calcium homeostasis in adults with cystic fibrosis. Osteoporos Int. 1999;10(2):102–108. doi: 10.1007/s001980050202. [DOI] [PubMed] [Google Scholar]
  2. Aris R. M., Lester G. E., Ontjes D. A. Bone loss physiology in critically ill patients. Chest. 1998 Oct;114(4):954–955. doi: 10.1378/chest.114.4.954. [DOI] [PubMed] [Google Scholar]
  3. Aris R. M., Renner J. B., Winders A. D., Buell H. E., Riggs D. B., Lester G. E., Ontjes D. A. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med. 1998 Feb 1;128(3):186–193. doi: 10.7326/0003-4819-128-3-199802010-00004. [DOI] [PubMed] [Google Scholar]
  4. Aris R. M., Stephens A. R., Ontjes D. A., Denene Blackwood A., Lark R. K., Hensler M. B., Neuringer I. P., Lester G. E. Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am J Respir Crit Care Med. 2000 Nov;162(5):1674–1678. doi: 10.1164/ajrccm.162.5.2002100. [DOI] [PubMed] [Google Scholar]
  5. Baecke J. A., Burema J., Frijters J. E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982 Nov;36(5):936–942. doi: 10.1093/ajcn/36.5.936. [DOI] [PubMed] [Google Scholar]
  6. Bhudhikanok G. S., Lim J., Marcus R., Harkins A., Moss R. B., Bachrach L. K. Correlates of osteopenia in patients with cystic fibrosis. Pediatrics. 1996 Jan;97(1):103–111. [PubMed] [Google Scholar]
  7. Bhudhikanok G. S., Wang M. C., Marcus R., Harkins A., Moss R. B., Bachrach L. K. Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr. 1998 Jul;133(1):18–27. doi: 10.1016/s0022-3476(98)70172-6. [DOI] [PubMed] [Google Scholar]
  8. Bonfield T. L., Panuska J. R., Konstan M. W., Hilliard K. A., Hilliard J. B., Ghnaim H., Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2111–2118. doi: 10.1164/ajrccm.152.6.8520783. [DOI] [PubMed] [Google Scholar]
  9. Compston J. E. Vitamin D deficiency: time for action. Evidence supports routine supplementation for elderly people and others at risk. BMJ. 1998 Nov 28;317(7171):1466–1467. doi: 10.1136/bmj.317.7171.1466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Conway S. P., Morton A. M., Oldroyd B., Truscott J. G., White H., Smith A. H., Haigh I. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax. 2000 Sep;55(9):798–804. doi: 10.1136/thorax.55.9.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Elkin S. L., Fairney A., Burnett S., Kemp M., Kyd P., Burgess J., Compston J. E., Hodson M. E. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int. 2001;12(5):366–372. doi: 10.1007/s001980170104. [DOI] [PubMed] [Google Scholar]
  12. Finkelstein J. S., Klibanski A., Neer R. M., Doppelt S. H., Rosenthal D. I., Segre G. V., Crowley W. F., Jr Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1989 Oct;69(4):776–783. doi: 10.1210/jcem-69-4-776. [DOI] [PubMed] [Google Scholar]
  13. Grey A. B., Ames R. W., Matthews R. D., Reid I. R. Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax. 1993 Jun;48(6):589–593. doi: 10.1136/thx.48.6.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Haworth C. S., Selby P. L., Adams J. E., Mawer E. B., Horrocks A. W., Webb A. K. Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. Thorax. 2001 Apr;56(4):314–316. doi: 10.1136/thorax.56.4.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Haworth C. S., Selby P. L., Webb A. K., Adams J. E., Freemont T. J. Oral corticosteroids and bone pain after pamidronate in adults with cystic fibrosis. Lancet. 1999 May 29;353(9167):1886–1886. doi: 10.1016/s0140-6736(05)75096-0. [DOI] [PubMed] [Google Scholar]
  16. Haworth C. S., Selby P. L., Webb A. K., Dodd M. E., Musson H., McL Niven R., Economou G., Horrocks A. W., Freemont A. J., Mawer E. B. Low bone mineral density in adults with cystic fibrosis. Thorax. 1999 Nov;54(11):961–967. doi: 10.1136/thx.54.11.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Haworth C. S., Selby P. L., Webb A. K., Mawer E. B., Adams J. E., Freemont T. J. Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis. Lancet. 1998 Nov 28;352(9142):1753–1754. doi: 10.1016/S0140-6736(05)79826-3. [DOI] [PubMed] [Google Scholar]
  18. Haworth C. S., Webb A. K., Egan J. J., Selby P. L., Hasleton P. S., Bishop P. W., Freemont T. J. Bone histomorphometry in adult patients with cystic fibrosis. Chest. 2000 Aug;118(2):434–439. doi: 10.1378/chest.118.2.434. [DOI] [PubMed] [Google Scholar]
  19. Henderson R. C., Specter B. B. Kyphosis and fractures in children and young adults with cystic fibrosis. J Pediatr. 1994 Aug;125(2):208–212. doi: 10.1016/s0022-3476(94)70194-6. [DOI] [PubMed] [Google Scholar]
  20. Ionescu A. A., Nixon L. S., Evans W. D., Stone M. D., Lewis-Jenkins V., Chatham K., Shale D. J. Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):789–794. doi: 10.1164/ajrccm.162.3.9910118. [DOI] [PubMed] [Google Scholar]
  21. Knudson R. J., Lebowitz M. D., Holberg C. J., Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983 Jun;127(6):725–734. doi: 10.1164/arrd.1983.127.6.725. [DOI] [PubMed] [Google Scholar]
  22. Landon C., Rosenfeld R. G. Short stature and pubertal delay in male adolescents with cystic fibrosis. Androgen treatment. Am J Dis Child. 1984 Apr;138(4):388–391. doi: 10.1001/archpedi.1984.02140420054017. [DOI] [PubMed] [Google Scholar]
  23. Mawer E. B., Walls J., Howell A., Davies M., Ratcliffe W. A., Bundred N. J. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab. 1997 Jan;82(1):118–122. doi: 10.1210/jcem.82.1.3642. [DOI] [PubMed] [Google Scholar]
  24. Ott S. M., Aitken M. L. Osteoporosis in patients with cystic fibrosis. Clin Chest Med. 1998 Sep;19(3):555–567. doi: 10.1016/s0272-5231(05)70100-3. [DOI] [PubMed] [Google Scholar]
  25. Reid I. R. Preventing glucocorticoid-induced osteoporosis. N Engl J Med. 1997 Aug 7;337(6):420–421. doi: 10.1056/NEJM199708073370609. [DOI] [PubMed] [Google Scholar]
  26. Thomas M. K., Lloyd-Jones D. M., Thadhani R. I., Shaw A. C., Deraska D. J., Kitch B. T., Vamvakas E. C., Dick I. M., Prince R. L., Finkelstein J. S. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998 Mar 19;338(12):777–783. doi: 10.1056/NEJM199803193381201. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES